The post Revolut banking U.S. charter move signals de novo path appeared on BitcoinEthereumNews.com. In a strategic step toward its global ambitions, Revolut bankingThe post Revolut banking U.S. charter move signals de novo path appeared on BitcoinEthereumNews.com. In a strategic step toward its global ambitions, Revolut banking

Revolut banking U.S. charter move signals de novo path

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

In a strategic step toward its global ambitions, Revolut banking has taken a major regulatory leap in the United States by applying for a full bank charter.

Revolut seeks U.S. banking license to operate as full-service bank

U.K.-based fintech Revolut has formally applied for a U.S. banking license, a move that would allow the company to operate like a traditional bank in the world’s largest economy. The application, filed in 2024, would grant the firm direct access to key U.S. payment networks, including Fedwire and the Automated Clearing House, known as ACH. This would significantly reduce its reliance on intermediary partners.

Moreover, securing a U.S. bank charter would cement Revolut’s status as a regulated financial institution in a core market. The company aims to position itself as a global digital bank rather than a simple payments or money-transfer app. However, approval would subject the firm to stringent U.S. oversight and capital requirements.

From partnership model to direct banking presence

Today, Revolut offers accounts and payment services in the United States via a partnership with Lead Bank, a Kansas City-based institution. Through this arrangement, Revolut provides accounts and payment capabilities without holding its own U.S. banking charter. That said, the new license would enable Revolut to shift away from this dependence and become a direct participant in the U.S. banking system.

The planned charter could also allow Revolut to roll out new lending products in the country, including credit cards and personal loans. Moreover, regulators could authorize the firm to take insured deposits in its own name, expanding its revenue base beyond payment fees and foreign-exchange services.

Strategic pivot from acquisition to de novo charter

The U.S. license application follows Revolut’s decision in January to abandon plans to acquire an existing American bank. Instead, the company chose to pursue a so-called de novo banking license, which allows a new bank to launch from scratch under full regulatory review. This shift highlights management’s willingness to undergo a lengthier process in exchange for a tailor-made charter.

However, the de novo route typically involves rigorous scrutiny from U.S. banking supervisors. Regulators will assess the firm’s governance, risk controls and compliance capabilities, especially given its rapid growth and crypto-friendly profile. Moreover, any approval could come with conditions or phased permissions as authorities monitor operations.

Competitive landscape and comparison with crypto peers

The move comes shortly after crypto exchange Kraken secured a Federal Reserve “master account” for its banking arm. That direct Fed access gives Kraken entry to the central bank’s core payment system, setting a precedent for digital asset firms seeking deeper integration with traditional finance. In this context, Revolut’s U.S. ambitions underscore growing convergence between fintech, banking and crypto infrastructure.

Revolut banking ambitions in the United States mirror its broader strategy to become a one-stop platform for payments, savings, investing and digital assets. However, unlike a pure crypto exchange, the company is pursuing a universal-banking style footprint, blending app-based services with full regulatory licensing in major jurisdictions.

Regulatory milestones and valuation impact

Revolut has repeatedly described the U.S. market as central to its goal of building a global digital bank. Valued at about $75 billion, the firm could see a U.S. charter rank among its most significant regulatory milestones outside Europe. Moreover, a successful application may strengthen investor confidence in its long-term profitability and diversification plans.

The crypto-friendly firm already holds several bank licenses worldwide. It secured a restricted U.K. banking license in 2024, and it also operates under banking charters in other jurisdictions. However, it is still not recognized as a bank in every market where it offers services, leading to a patchwork of regulatory regimes and product availability.

Global footprint and future expansion

Revolut continues to expand its presence across multiple regions, blending its app-based model with local regulatory approvals. The U.S. license effort fits into this broader roadmap, which includes strengthening oversight, enhancing compliance and deepening access to domestic payment rails. That said, each jurisdiction’s regulatory regime could impose different obligations on the firm’s business model.

If approved, the American charter would likely replace its existing collaboration with Lead Bank over time, aligning U.S. operations with its more integrated set-ups in other countries. Moreover, direct access to networks like Fedwire and ACH could help the firm lower costs, improve transaction speed and compete more aggressively with established banks and fintech rivals.

In summary, Revolut’s U.S. banking license application marks a pivotal step in its push to become a fully regulated global digital bank, potentially reshaping its business model, regulatory profile and competitive standing in the American market.

Source: https://en.cryptonomist.ch/2026/03/05/revolut-banking-us-charter/

Market Opportunity
Union Logo
Union Price(U)
$0.001044
$0.001044$0.001044
-4.48%
USD
Union (U) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

a16z Targets $2 Billion Crypto Fund as Venture Capital Eyes Blockchain Recovery

a16z Targets $2 Billion Crypto Fund as Venture Capital Eyes Blockchain Recovery

Andreessen Horowitz’s crypto division, a16z crypto, is reportedly running $2 billion for its fifth crypto investment fund. This move from a firm is happening when
Share
Thenewscrypto2026/03/05 20:29
ArtGis Finance Partners with MetaXR to Expand its DeFi Offerings in the Metaverse

ArtGis Finance Partners with MetaXR to Expand its DeFi Offerings in the Metaverse

By using this collaboration, ArtGis utilizes MetaXR’s infrastructure to widen access to its assets and enable its customers to interact with the metaverse.
Share
Blockchainreporter2025/09/18 00:07
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11